FDA rejects Rexulti-Zoloft combo for PTSD

The FDA re­ject­ed Ot­su­ka and Lund­beck’s Rex­ul­ti and Zoloft com­bi­na­tion treat­ment for PTSD, months af­ter rais­ing con­cerns about the reg­i­men’s ef­fi­ca­cy at an ad­vi­so­ry com­mit­tee …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.


Source link
Related Articles

Related posts:

  1. FDA Panel Rejects Combo Drug for PTSD
  2. FDA Advisory Committee Votes Against Recommending Brexpiprazole Plus Sertraline for PTSD
  3. New analysis reveals hidden economic burden of PTSD in the UK
  4. People’s Pharmacy: Is there a way to petition the FDA to change a drug’s classification?
See also  A UPMC doctor waited years for a needed drug to get approval. The FDA finally gave it - Pittsburgh Post-Gazette
↑
Exit mobile version